Article

Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease

2023-05-29

Abstract excerpt

<h4> Abstract </h4> <h4>Importance</h4> Forty percent of Parkinson’s disease patients develop levodopa-induced-dyskinesia (LiD) within 4 years of starting levodopa. The genetic basis of LiD remains poorly understood, and there have been few well powered studies. <h4>Objective</h4> To discover common genetic variants in the PD population that increase the probability of developing LiD. <h4>Design, setting and Parti...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0331823d-8714-57c5-841a-48cde78770f0
DOI: 10.1101/2023.05.24.23290362

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s diseaseDOI 10.1101/2023.05.24.23290362Read

Dopamine pathway and Parkinson’s risk variants are associated with levodopa-induced dyskinesiaSemantic proximity Read

Dopamine Pathway and Parkinson's Risk Variants Are Associated with Levodopa-Induced Dyskinesia.Semantic proximity Read

Exome-wide association study of levodopa-induced dyskinesia in Parkinson's disease.Semantic proximity Read

Genome-wide association study of Parkinson’s disease progression biomarkers in 12 longitudinal patients’ cohortsSemantic proximity Read

Monogenic Parkinson’s Disease and the Impact of<i>APOE</i>E4: A Case-Control StudySemantic proximity Read

Novel Parkinson's disease risk loci identified through a meta-analysis of genome-wide association studies.Semantic proximity Read

Identification of genetic modifiers of age-at-onset for familial Parkinson's disease.Semantic proximity Read

Analysis of rare Parkinson’s disease variants in millions of peopleSemantic proximity Read

Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson's disease.Semantic proximity Read

Shared and Sex-Specific Genetic Risk for Parkinson’s Disease Risk Across European PopulationsSemantic proximity Read

Pharmacogenetic profile and the development of the dyskinesia induced by levodopa-therapy in Parkinson's disease patients: a population-based cohort study.Semantic proximity Read

Genetic Associations With Rapid Motor and Cognitive Deterioration in Parkinson’s DiseaseSemantic proximity Read